Selected Publications
Patricia Delai, Mona Al Mukaddam, Geneviève Baujat, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Kim Croskery, Jean-Luc Delhay, Christelle Pommie, Robert J. Pignolo: Incidence and management of skin adverse events in patients receiving palovarotene for the treatment of fibrodysplasia ossificans progressiva Poster Presentation at ICCBH Salzburg, Austria : 2024.
Richard Keen, Robert J. Pignolo, Mona Al Mukaddam, Geneviève Baujat, Angela M. Cheung, Carmen De Cunto, Edward C. Hsiao, Jean-Luc Delhay, Fei Shih, Andrew Strahs, Frederick S. Kaplan: Assessments of bone mineralisation, strength and fracture of the lumbar spine in patients with fibrodysplasia ossificans progressiva treated with palovarotene: Data from the phase III MOVE trial and a phase II open-label extension
Poster Presentation at ICCBH Salzburg, Austria : 2024.
Javier Ocampo Mascaro, Richie Tran, Staci Kallish, Jessica Berman, Mona Al Mukaddam: Clinical Features Of Adult Hypophosphatasia And Correlation Between Laboratory Findings And Patient’s Symptomatology: A Retrospective Review At The Penn Bone Center. Poster Session Endocrine Society Annual Meeting : 2024.
Javier Ocampo Mascaro, Pamela Wax, Mona Al Mukaddam: Adult-Onset Hypophosphatasia Presenting as Low Alkaline Phosphatase Level Following Denosumab Use for Osteoporosis.
Endocrine Society Annual Meeting : 2024.
Deborah Wenkert, Frederick S. Kaplan, Robert J. Pignolo, Edward C. Hsiao, Mona M Al Mukaddam, Eric Soliman, Victoria Smith, Pankaj Bhargava: ANDECAL, A Phase 2/3 study to determine the efficacy of the MMP9-inhibitor Andecaliximab to block new heterotopic ossification in FOP: Methodology for Part 1 of the Study
Poster Presentation at ICCBH Salzburg, Austria : 2024.
Edna E. Mancilla, Geneviève Baujat, Mona Al Mukaddam, Javier Bachiller-Corral, Staffan K. Berglund, Carmen De Cunto, Patricia Delai, Richard Keen, Riccardo Papa, Robert J. Pignolo, Sally Lanar, Alexia Marrel, Alexander Artyomenko, Kim Croskery, Christelle Pommie, Edward C. Hsiao: The impact of palovarotene on patients with fibrodysplasia ossificans progressiva: Results from participant interviews in the phase III PIVOINE trial.
Poster Presentation at ICCBH Salzburg, Austria : 2024.
Lounev V, Groppe JC, Brewer N, Wentworth KL, Smith V, Xu M, Schomburg L, Bhargava P, Al Mukaddam M, Hsiao EC, Shore EM, Pignolo RJ, Kaplan FS: Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice. J Bone Miner Res : 2024.
Bassam AlHamer, Ajit Singh, Carmen Patrascu, Mona Al Mukaddam: Tumor induced osteomalacia due to sarcomatoid non-small cell lung carcinoma confounded by drug-induced Fanconi syndrome
JCEM Case Reports : 2024.
Pignolo RJ, Al Mukaddam M, Baujat G, Brown MA, De Cunto C, Hsiao EC, Keen R, Le Quan Sang KH, Grogan DR, Marino R, Strahs AR, Kaplan FS.: Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva BMC Med Res Methodol : 2023.
Pignolo RJ, Al Mukaddam M, Baujat G, Brown MA, De Cunto C, Hsiao EC, Keen R, Le Quan Sang KH, Grogan DR, Marino R, Strahs AR, Kaplan FS.:
Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva.
BMC Med Res Methodol : 2023.
Academic Contact Information
3rd floor Penn Medicine University City
3737 Market Street
Philadelphia,
PA
19104
Phone: 215-662-9905
Patient appointments: 800-789-7366